Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

Illustration for the ASTMH Fundraiser

Throughout February, March And April, All Donations Made To Parasites Without Borders Will Be Matched By PWB And Donated To ASTMH

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

March 2, 2023

Fatal Fulminant Cerebral Edema in Six Children With SARS-CoV-2 Omicron BA.2 Infection in Taiwan | Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children | COVID-19 vaccines versus pediatric hospitalization | Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 | Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children | Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid | Effect of covid-19 vaccination on long covid: systematic review | FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses | Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 | Certifying Deaths Due to Coronavirus Disease 2019

February 23, 2023

Sex differences in cardiovascular complications and mortality in hospital patients with covid-19 | Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults | A third vaccine dose equalizes the levels of effectiveness | Sotrovimab retains activity against SARS-CoV-2 Omicron variant | Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients | Viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals | Serological response to vaccination in post-acute sequelae of COVID | Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection | Past SARS-CoV-2 infection protection against re-infection | Postacute Sequelae of SARS-CoV-2 in University Setting
Portrait of handsome young man preparing for blood donation at med center with nurse helping

February 16, 2023

Intra-Host Evolution Provides for the Continuous Emergence of SARS-CoV-2 Variants | A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273 | The political polarization of COVID-19 treatments among physicians and laypeople in the United States | Maternal mRNA covid-19 vaccination during pregnancy and delta or omicron infection or hospital admission in infants: test negative design study | SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster | The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England

February 9, 2023

The Negative Effect of Preexisting Immunity on Influenza Vaccine | Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells | Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults | Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection | Early Treatment with Pegylated Interferon Lambda for Covid-19 | Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms | Consistency of covid-19 trial preprints with published reports | Peru confirms H5N1 avian flu in marine mammals | Incidence of Chronic Spontaneous Urticaria | COVID-19 Mortality and Progress Toward Vaccinating Older Adults

February 2, 2023

Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection | Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods | Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients | Effectiveness of Bivalent Boosters against Severe Omicron Infection | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults | Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US | Association of culturable-virus detection and household transmission of SARS-CoV-2 – California and Tennessee, 2020–2022 | Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients

January 24, 2023

Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19 | Early and Increased Influenza Activity Among Children — Tennessee | SARS-CoV-2 variant-related abnormalities detected by prenatal MRI | COVID-19 vaccines versus pediatric hospitalization | Persistent COVID-19 Symptoms at 6 Months After Onset | Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study | Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases | Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

1280px-US_CDC_logo.svg

Centers for Disease Control, US

ProMED-Logo

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top